Nobel Biocare Soared on October 24, 2011 on Report It Could be M&A Target

Nobel Biocare Holding AG (NOBN) rose the most in almost 12 years in Zurich trading after NZZ am Sonntag reported that EQT Partners AB and Bain Capital LLC are considering buying the Swiss dental-implant maker. Nobel Biocare gained 18 percent to 11.76 Swiss francs at 4:40 p.m., valuing the company at 1.46 billion francs ($1.65 billion). The stock climbed as much as 21 percent, the biggest intraday increase since Jan. 27, 2000. The stock, which gained 9.4 percent Oct. 21 on takeover speculation, has fallen 87 percent since reaching a record in April 2007.

Back to news